Developments Oramed, Genomma Lab in JV for oral COVID-19 vaccine in Mexico; BD in Latin America Oravax Medical, a unit of Oramed Pharmaceuticals (NASDAQ, TASE:ORMP), and Genomma Lab Internacional (BMV:LABB) formed of a 50/50 joint venture to develop and commercialize Oravax’s oral COVID-19 vaccine candidate... November 18, 2021